New York Office of Cannabis Management Issues ‘Quarantine’ for Caffeine-Infused Cannabis Products

Medcard

Over the summer, the New York Office of Cannabis Management (OCM) issued a stop order for the production of caffeine-infused cannabis pills manufactured by Hudson Cannabis for cannabis brand 1906, the New York Post reports. In a July 24 OCM “quarantine” reviewed by the Post, two OCM inspectors said that “Evidence supports that ingredients used in product are not allowed to be used in cannabis products.” 

The quarantined products include “Go” – a tincture which contains 80 milligrams of caffeine, 2 milligrams of THC and 5 milligrams of CBD – and “Genius,” a pill that includes 20 milligrams of caffeine, 2.5 milligrams of THC, and 5 milligrams of CBD and CBG. Both products have been on the market since February 2023, the report says. The order states that the products “may jeopardize public health or safety.”    

In a statement to the Post, Melany Dobson, co-founder of Hudson Cannabis, said the company is “surprised by this decision from the State to quarantine products that have been on the market for over 18 months, are sold legally in States across the nation, and as far as we know have had zero reported adverse effects.”  

Read More Here…

Bud Digest

Scroll to Top